0001127602-21-024770.txt : 20210902 0001127602-21-024770.hdr.sgml : 20210902 20210902162559 ACCESSION NUMBER: 0001127602-21-024770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galson Steven K CENTRAL INDEX KEY: 0001495328 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 211233558 MAIL ADDRESS: STREET 1: C/O BIOCRYST PHARMACEUTICALS, INC. STREET 2: 4505 EMPEROR BLVD, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-09-01 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001495328 Galson Steven K 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Non-Qualified Stock Option 16.15 2021-09-01 4 A 0 60000 0 A 2031-09-01 Common Stock 60000 60000 D Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan. The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021. /s/ Jessica Dickerson, by power of attorney 2021-09-02